Product Information
MEROPENEM IV 1 GM VIAL is a generic product labeled by Armas Pharmaceuticals Inc., priced at $4.6687 per EA under NDC 72485041210. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Aug 18, 2022. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the Meropenem market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 g/20mL
Manufacturer
Armas Pharmaceuticals Inc.NDC
72485041210
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
MEROPENEMApproval Type
Generic (ANDA)
FDA Application
ANDA216154FDA Approved
8/18/2022
TE Code
AP
On Market Since
5/31/2023
Pharmacological Classes
Price Statistics
The NADAC for MEROPENEM IV 1 GM VIAL has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 19.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6687 per EA |
|---|---|
| All-time high | $7.6153 (Nov 13, 2024) |
| All-time low | $4.6687 (Aug 19, 2026) |
| 52-week high | $5.8381 |
| 52-week low | $4.6687 |
| Median price | $5.7092 |
| Average price | $5.8459 |
| Largest weekly change | +15.4% (Oct 23, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEROPENEM IV 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MEROPENEM IV 1 GM VIAL, manufactured by Armas Pharmaceuticals Inc., is $4.6687 per EA (NDC 72485041210), effective Aug 19, 2026.
How has the price of MEROPENEM IV 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for MEROPENEM IV 1 GM VIAL has declined 19.9%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MEROPENEM IV 1 GM VIAL?
Since Apr 17, 2024, the NADAC for MEROPENEM IV 1 GM VIAL has ranged from a low of $4.6687 (Aug 19, 2026) to a high of $7.6153 (Nov 13, 2024), with a median of $5.7092 per EA.
Are there cheaper alternatives to MEROPENEM IV 1 GM VIAL?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MEROPENEM IV 1 GM VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures MEROPENEM IV 1 GM VIAL?
MEROPENEM IV 1 GM VIAL (NDC 72485041210) is labeled by Armas Pharmaceuticals Inc., and CMS classifies it as a generic product.